Publicaciones Imprimir Abdelmoneim YM, Lou Y, Advani P, Khoor A, Sharma A, Parent EE. FES avid pulmonary adenocarcinoma and confounding ER+ breast carcinoma. Radiol Case Rep. 2025 Jan; 20 (1):801-804 Epub 2024 Nov 14 View PubMed Kawatani K, Omana Suarez G, Perkerson RB 3rd, Parent EE, Nambara T, Knight JA, Parsons TM, Gupta K, Shue F, Alnobani A, Vibhute P, Cai H, Guerrero-Cazares H, Copland JA 3rd, Quinones-Hinojosa A, Kanekiyo T. Human iPSC-derived MSCs induce neurotrophic effects and improve metabolic activity in acute neuronal injury models. J Neurosci. 2024 Nov 4 Epub 2024 Nov 04 View PubMed Parent EE, Gleba JJ, Knight JA, Kenderian SJ, Copland JA 3rd, Cai H. Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer. Mol Imaging Biol. 2024 Oct; 26 (5):847-857 Epub 2024 Aug 22 View PubMed Kase AM, Gleba J, Miller JL, Miller E, Petit J, Barrett MT, Zhou Y, Parent EE, Cai H, Knight JA, Orme J, Reynolds J, Durham WF, Metz TM, Meurice N, Edenfield B, Alasonyalilar Demirer A, Bilgili A, Hickman PG, Pawlush ML, Marlow L, Wickland DP, Tan W, Copland JA 3rd. Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer. Mol Cancer Ther. 2024 Jun 4; 23 (6):823-835 View PubMed Savir-Baruch B, Parent E. Beyond the AJR: PET/MRI Using (68)Ga-RM2 Has Superior Performance to MRI Alone in the Localization of Lesions in Patients With Biochemical Failure After Prostate Cancer Treatment. AJR Am J Roentgenol. 2024 May 15 [Epub ahead of print] View PubMed Bullock C, McCann M, Sharma A, Young JR, Metcalfe AM, Parent EE. FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis. Radiol Case Rep. 2023 Nov; 18 (11):3932-3935 Epub 2023 Aug 28 View PubMed Li KP, Gleba JJ, Parent EE, Knight JA, Copland JA 3rd, Cai H. Radiosynthesis and Preliminary Evaluation of [(11)C]SSI-4 for the Positron Emission Tomography Imaging of Stearoyl CoA Desaturase 1. Mol Pharm. 2023 Aug 7; 20 (8):4129-4137 Epub 2023 July 06 View PubMed Orciuolo J, Sharma A, Parent EE, Accurso JM, Jain MK, Young JR. Incidental Airway Findings on PET/CT with (18)F-PSMA. J Nucl Med. 2023 Jun; 64 (6):993 Epub 2023 Jan 05 View PubMed Gococo-Benore DA, Kuhlman J, Parent EE, Sharma A, Accurso J, Yang M, Kendi AT, Johnson G, Sonbol MB, Hobday T, Halfdanarson TR, Starr J. Evaluation of Hepatotoxicity from Peptide Receptor Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors and a Very High Liver Tumor Burden. J Nucl Med. 2023 Jun; 64 (6):880-884 Epub 2023 Apr 20 View PubMed Brahmbhatt P, Ataei F, Parent EE, Sharma A. Atypically Intense Pharmacologically Induced Brown Fat Activation on FDG PET/CT. Clin Nucl Med. 2023 Mar 1; 48 (3):233-236 Epub 2023 Jan 10 View PubMed Parent EE, Fowler AM. Nuclear Receptor Imaging In Vivo-Clinical and Research Advances. J Endocr Soc. 2023 Jan 6; 7 (3):bvac197 Epub 2022 Dec 31 View PubMed Davis J, Kimbrough EO, Alhaj Moustafa M, Jiang L, Gupta V, Parent E, Tun HW. Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma. J Blood Med. 2023; 14:49-55 Epub 2023 Jan 22 View PubMed Bilen MA, Akintayo A, Liu Y, Abiodun-Ojo O, Kucuk O, Carthon BC, Schuster DM, Parent EE. Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [(68)Ga]Ga DOTATATE PET-CT. Cancers (Basel). 2022 Dec 8; 14 (24) Epub 2022 Dec 08 View PubMed Ataei F, Sharma A, Stanborough R, Parent EE. FDG PET-MRI evaluation of synchronous gallbladder adenocarcinoma and POEMS syndrome. Radiol Case Rep. 2022 Nov; 17 (11):4294-4298 Epub 2022 Sept 13 View PubMed Parent EE, Savir-Baruch B, Gayed IW, Almaguel F, Chin BB, Pantel AR, Armstrong E, Morley A, Ippisch RC, Flavell RR. (177)Lu-PSMA Therapy. J Nucl Med Technol. 2022 Sep; 50 (3):205-212 Epub 2022 July 26 View PubMed Parent EE, Kase AM. A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer. Cancers (Basel). 2022 Sep 1; 14 (17) Epub 2022 Sept 01 View PubMed Parent EE, Savir-Baruch B, Gayed IW, Almaguel F, Chin B, Pantel AR, Armstrong E, Morley A, Ippisch RC, Flavell RR. JNMT continuing education: (177)Lu PSMA therapy. J Nucl Med Technol. 2022 Jul 26 Epub 2022 July 26 View PubMed Kase AM, Tan W, Copland JA 3rd, Cai H, Parent EE, Madan RA. The Continuum of Metastatic Prostate Cancer: Interpreting PSMA PET Findings in Recurrent Prostate Cancer. Cancers (Basel). 2022 Mar 8; 14 (6) Epub 2022 Mar 08 View PubMed Parent EE, Sethi I, Nye J, Holder C, Olson JJ, Switchenko J, Tade F, Akin-Akintayo OO, Abiodun-Ojo OA, Akintayo A, Schuster DM. 82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis. Q J Nucl Med Mol Imaging. 2022 Mar; 66 (1):74-81 Epub 2019 Dec 09 View PubMed Gococo-Benore DA, Parent E, Sharma A, Accurso J, Yang M, Kendi AT, Sonbol B, Halfdanarson TR, Starr JS. Hepatotoxicity from peptide receptor radionuclide therapy (prrt) in neuroendocrine tumors (nets) patients with very high liver tumor burden. Pancreas. 2022; 51(3):E47. Sharma A, Navaz AJ, Pandey MK, Parent EE. Unusual Increased Blood Pool Activity on 68Ga-DOTATATE PET/CT in a Patient With Metastatic Neuroendocrine Disease. Clin Nucl Med. 2022 Feb 1; 47 (2):137-139 View PubMed Kase AM, Bullock C, Parrondo R, Alhaj Moustafa M, Iqbal M, Li KD, Parent EE, Tun H. Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation. Blood Lymphat Cancer. 2022; 12:17-21 Epub 2022 Mar 23 View PubMed Covington MF, Parent EE, Dibble EH, Rauch GM, Fowler AM. Advances and Future Directions in Molecular Breast Imaging. J Nucl Med. 2022 Jan; 63 (1):17-21 Epub 2021 Dec 09 View PubMed Kimbrough EO, Jiang L, Parent EE, Bourgeois K, Alhaj Moustafa M, Tun HW, Iqbal M. Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes. J Blood Med. 2022; 13:663-671. Epub 2022 Nov 14. View PubMed Advani P, Chumsri S, Pai T, Li Z, Sharma A, Parent E. Temporal metabolic response to mRNA COVID-19 vaccinations in oncology patients. Ann Nucl Med. 2021 Nov; 35 (11):1264-1269 Epub 2021 Aug 31 View PubMed Parent EE, Johnson DR, Gleason T, Villanueva-Meyer JE. Neuro-Oncology Practice Clinical Debate: FDG PET to differentiate glioblastoma recurrence from treatment-related changes. Neurooncol Pract. 2021 Oct; 8 (5):518-525 Epub 2021 May 04 View PubMed Kotecha R, Aboian M, Nabavizadeh SA, Parent EE, Trifiletti DM, Chao ST. Letter regarding "Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients-a report of the PET/RANO group": 18F-fluciclovine and target volume delineation. Neuro Oncol 2021 Aug 2; 23 (8):1408-1409 View PubMed Pai TS, Rojas C, Wasserman MC, Parent EE, Cornell L, Chumsri S. Asymptomatic coronavirus disease 2019 mimicking metastatic breast cancer on positron emission tomography/computed tomography imaging. Radiol Case Rep. 2021 Aug; 16 (8):2226-2230 Epub 2021 June 13 View PubMed Akintayo AA, Bilen MA, Abiodun-Ojo OA, Kucuk O, Carthon B, Chen Z, Jani AB, Parent EE, Schuster DM. Exploratory study of (18)F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer. Am J Nucl Med Mol Imaging. 2021; 11 (3):218-229 Epub 2021 June 15 View PubMed Parent EE, Patel D, Nye JA, Li Z, Olson JJ, Schuster DM, Goodman MM. [(18)F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis. EJNMMI Res. 2020 Dec 7; 10 (1):148 Epub 2020 Dec 07 View PubMed Dudgeon MG, Sonavane SK, Parent EE, Khoor A, Thomas M. Co-existent Epicardial Paraganglioma and Anterior Mediastinal Thymoma. J Radiol Case Rep. 2020 Oct; 14 (10):16-30 Epub 2020 Oct 31 View PubMed Bailey R, Sharma A, Parent EE. Carney-Stratakis Syndrome presenting as occult mediastinal paraganglioma. Radiol Case Rep. 2020 Sep; 15 (9):1528-1531 Epub 2020 July 04 View PubMed Agely A, Sharma A, Parent EE, Nawaz A, Jain MK. Isolated Intravascular Prostate Carcinoma Recurrence Confirmed With 18F-Fluciclovine PET/CT and MRI. Clin Nucl Med. 2020 Jun; 45 (6):442-443 View PubMed Brugarolas P, Comstock J, Dick DW, Ellmer T, Engle JW, Lapi SE, Liang SH, Parent EE, Kishore Pillarsetty NV, Selivanova S, Sun X, Vavere A, Scott PJH, Society of Nuclear Medicine and Molecular Imaging Radiopharmaceutical Sciences Council. Fifty Years of Radiopharmaceuticals. J Nucl Med Technol. 2020 Jun; 48 (Suppl 1):34S-39S View PubMed Nanni C, Zanoni L, Bach-Gansmo T, Minn H, Willoch F, Bogsrud TV, Edward EP, Savir-Baruch B, Teoh E, Ingram F, Fanti S, Schuster DM. [(18)F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0. Eur J Nucl Med Mol Imaging. 2019 Dec 11 [Epub ahead of print] View PubMed Parent E, Sharma A, Jain M. Amino Acid PET Imaging of Glioma Current Radiology Reports. April 2019; 7(5). Savir-Baruch B, Banks KP, McConathy JE, Molchanova-Cook OP, Parent EE, Takalkar A, Tulchinsky M, Yu JQ, Subramaniam RM, Schuster DM. ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer. Clin Nucl Med. 2018 Dec; 43 (12):909-917 View PubMed Parent EE, Benayoun M, Ibeanu I, Olson JJ, Hadjipanayis CG, Brat DJ, Adhikarla V, Nye J, Schuster DM, Goodman MM. [(18)F]Fluciclovine PET discrimination between high- and low-grade gliomas. EJNMMI Res. 2018 Jul 25; 8 (1):67 Epub 2018 July 25 View PubMed Parent EE, Schuster DM. Update on (18)F-Fluciclovine PET for Prostate Cancer Imaging. J Nucl Med. 2018 May; 59 (5):733-739 Epub 2018 Mar 09 View PubMed Gauvain K, Ponisio MR, Barone A, Grimaldi M, Parent E, Leeds H, Goyal M, Rubin J, McConathy J. (18)F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors. Neurooncol Pract. 2018 Mar; 5 (1):28-36 Epub 2017 May 25 View PubMed Fraum TJ, Fowler KJ, McConathy J, Parent EE, Dehdashti F, Grigsby PW, Siegel BA. PET/MRI for the body imager: abdominal and pelvic oncologic applications. Abdom Imaging. 2015 Aug; 40 (6):1387-404 View PubMed Lee BC, Dence CS, Zhou H, Parent EE, Welch MJ, Katzenellenbogen JA. Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-gamma ligands: potential positron emission tomography imaging agents. Nucl Med Biol. 2009 Feb; 36 (2):147-53 View PubMed Parent EE, Dence CS, Sharp TL, Welch MJ, Katzenellenbogen JA. 7alpha-18F-fluoromethyl-dihydrotestosterone and 7alpha-18F-fluoromethyl-nortestosterone: ligands to determine the role of sex hormone-binding globulin for steroidal radiopharmaceuticals. J Nucl Med. 2008 Jun; 49 (6):987-94 Epub 2008 May 15 View PubMed Fleming SA, Parent AA, Parent EE, Pincock JA, Renault L. Mechanistic analysis of the photocycloaddition of silyl-tethered alkenes. J Org Chem. 2007 Dec 7; 72 (25):9464-70 Epub 2007 Nov 13 View PubMed Parent EE, Carlson KE, Katzenellenbogen JA. Synthesis of 7alpha-(fluoromethyl)dihydrotestosterone and 7alpha-(fluoromethyl)nortestosterone, structurally paired androgens designed to probe the role of sex hormone binding globulin in imaging androgen receptors in prostate tumors by positron emission tomography. J Org Chem. 2007 Jul 20; 72 (15):5546-54 Epub 2007 June 22 View PubMed Parent EE, Dence CS, Jenks C, Sharp TL, Welch MJ, Katzenellenbogen JA. Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging. J Med Chem. 2007 Mar 8; 50 (5):1028-40 View PubMed Parent EE, Jenks C, Sharp T, Welch MJ, Katzenellenbogen JA. Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide. Nucl Med Biol. 2006 Aug; 33 (6):705-13 Epub 2006 July 21 View PubMed Parent EE, Dence CS, Sharp TL, Welch MJ, Katzenellenbogen JA. Synthesis and biological evaluation of a fluorine-18-labeled nonsteroidal androgen receptor antagonist, N-(3-[18F]fluoro-4-nitronaphthyl)-cis-5-norbornene-endo-2,3-dicarboxylic imide. Nucl Med Biol. 2006 Jul; 33 (5):615-24 View PubMed Bigott HM, Parent E, Luyt LG, Katzenellenbogen JA, Welch MJ. Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m PET imaging of estrogen receptors. Bioconjug Chem. 2005 Mar-Apr; 16 (2):255-64 View PubMed Fleming SA, Ward SC, Mao C, Parent EE. 2+2 Photocyclization Spectrum. 2002; 15(3):8-14. PST-20445439 Inicio Publicaciones